GLP Weekly: How one-time CRISPR shot could obliterate lower back pain; Questionable ‘litigation finance’ tool pays for glyphosate lawsuits; and more!

GLP Features Articles by GLP staff and contributors

How a one-time CRISPR shot could obliterate lower back pain Ricki Lewis Viewpoint: Pouring greed on an ethical fire—Questionable ‘litigation finance’ scam funds glyphosate-cancer lawsuit mill David Zaruk ‘GMOs are banned in Europe’ and 3 other popular biotech crop myths busted Michael Stebbins Why this attempt to cure an inherited form of blindness with CRISPR is so important Kostas Vavitsas Viewpoint: Why GMO crops are planet’s best hope for sustainability Eshna Gogia Tired all the time? Searching for genetic links to chronic fatigue syndrome Ben Locwin We have a marijuana shortage. Bioengineered yeast could solve that problem. Sarah LaFramboise How the quest to bake a better banana bread helps us understand GMOs Lucy Stitzer Why efforts to contain Ebola through experimental vaccines could change Uganda’s opposition to GMO crops Peter Wamboga-Mugirya Glimpse into the future? 2029 ‘press release’ touts services for designer babies Jamie Metzl